MAPT and early-onset autosomal dominant Alzheimer disease: These properties make N-benzylpiperidine derivatives promising candidates in drug discovery, particularly for multi-targeted approaches in treating Alzheimer’s disease targeting oxidative stress, cholinergic deficits, neuroinflammation, amyloid-beta (Aβ) accumulation, and tau protein hyperphosphorylation in AD.